Search hospitals > Alberta > EDMONTON
University of Alberta Hospital
Claim this profileEDMONTON, Alberta T6G 2B7
Global Leader in Stroke
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Cancer
Conducts research for High Blood Pressure
Conducts research for Acute Lymphoblastic Leukemia
425 reported clinical trials
91 medical researchers
Summary
University of Alberta Hospital is a medical facility located in EDMONTON, Alberta. This center is recognized for care of Stroke, Adult T-Cell Leukemia/Lymphoma, Cancer, High Blood Pressure, Acute Lymphoblastic Leukemia and other specialties. University of Alberta Hospital is involved with conducting 425 clinical trials across 1,117 conditions. There are 91 research doctors associated with this hospital, such as Sarah J. McKillop, Brian H. Buck, MD, FRCPC, Tim Darsaut, MD, and Eric Wong, MD.Area of expertise
1Stroke
Global Leader2Adult T-Cell Leukemia/Lymphoma
Global LeaderStage IV
Stage II
FLT3 positive
Top PIs
Sarah J. McKillopUniversity of Alberta Hospital5 years of reported clinical research
Studies Cancer
Studies Cystic Tumor
30 reported clinical trials
74 drugs studied
Brian H. Buck, MD, FRCPCUniversity of Alberta1 year of reported clinical research
Studies Stroke
Studies Bleeding
11 reported clinical trials
18 drugs studied
Tim Darsaut, MDUniversity of Alberta Hospital13 years of reported clinical research
Studies Intracranial Aneurysms
Studies Superior Mesenteric Artery Aneurysm
8 reported clinical trials
14 drugs studied
Eric Wong, MDBeth Israel Deaconess Medical Center1 year of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
9 reported clinical trials
16 drugs studied
Clinical Trials running at University of Alberta Hospital
Testicular cancer
Acute Lymphoblastic Leukemia
Crohn's Disease
Stroke
Atrial Fibrillation
Fragile X Syndrome
Spinal Cord Injury
Cancer
Testicular Carcinoma
Ovarian Carcinoma
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Alberta Hospital?
Where is University of Alberta Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Alberta Hospital accept?
What awards or recognition has University of Alberta Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.